Click for best price
Prostate Cancer Biomarker Market Size, Share 2024
This research report provides a comprehensive analysis of the Prostate Cancer Biomarker market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Prostate Cancer Biomarker market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Prostate Cancer Biomarker, challenges faced by the industry, and potential opportunities for market players.
The global Prostate Cancer Biomarker market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Prostate Cancer Biomarker market presents opportunities for various stakeholders, including Hospitals, Clinics. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Prostate Cancer Biomarker market. Additionally, the growing consumer demand present avenues for market expansion.
The global Prostate Cancer Biomarker market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.
Key Features:
The research report on the Prostate Cancer Biomarker market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Prostate Cancer Biomarker market.
Market Overview: The report provides a comprehensive overview of the Prostate Cancer Biomarker market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Urine, Blood), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Prostate Cancer Biomarker market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Prostate Cancer Biomarker market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Prostate Cancer Biomarker market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Prostate Cancer Biomarker market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Prostate Cancer Biomarker market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Prostate Cancer Biomarker market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Prostate Cancer Biomarker, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Prostate Cancer Biomarker market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Prostate Cancer Biomarker market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Urine
Blood
Serum
Market segment by Application
Hospitals
Clinics
Cancer Institutes
Global Prostate Cancer Biomarker Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Biomarker, market overview.
Chapter 2: Global Prostate Cancer Biomarker market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Biomarker company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Biomarker Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
98 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Biomarker Overall Market Size
2.1 Global Prostate Cancer Biomarker Market Size: 2023 VS 2030
2.2 Global Prostate Cancer Biomarker Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Biomarker Players in Global Market
3.2 Top Global Prostate Cancer Biomarker Companies Ranked by Revenue
3.3 Global Prostate Cancer Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Biomarker Companies in Global Market, by Revenue in 2023
3.5 Global Companies Prostate Cancer Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Biomarker Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Biomarker Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Biomarker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Biomarker Market Size Markets, 2023 & 2030
4.1.2 Urine
4.1.3 Blood
4.1.4 Serum
4.2 By Type - Global Prostate Cancer Biomarker Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Biomarker Revenue, 2019-2024
4.2.2 By Type - Global Prostate Cancer Biomarker Revenue, 2025-2030
4.2.3 By Type - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Biomarker Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Cancer Institutes
5.2 By Application - Global Prostate Cancer Biomarker Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Biomarker Revenue, 2019-2024
5.2.2 By Application - Global Prostate Cancer Biomarker Revenue, 2025-2030
5.2.3 By Application - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Biomarker Market Size, 2023 & 2030
6.2 By Region - Global Prostate Cancer Biomarker Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Biomarker Revenue, 2019-2024
6.2.2 By Region - Global Prostate Cancer Biomarker Revenue, 2025-2030
6.2.3 By Region - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Biomarker Revenue, 2019-2030
6.3.2 US Prostate Cancer Biomarker Market Size, 2019-2030
6.3.3 Canada Prostate Cancer Biomarker Market Size, 2019-2030
6.3.4 Mexico Prostate Cancer Biomarker Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Biomarker Revenue, 2019-2030
6.4.2 Germany Prostate Cancer Biomarker Market Size, 2019-2030
6.4.3 France Prostate Cancer Biomarker Market Size, 2019-2030
6.4.4 U.K. Prostate Cancer Biomarker Market Size, 2019-2030
6.4.5 Italy Prostate Cancer Biomarker Market Size, 2019-2030
6.4.6 Russia Prostate Cancer Biomarker Market Size, 2019-2030
6.4.7 Nordic Countries Prostate Cancer Biomarker Market Size, 2019-2030
6.4.8 Benelux Prostate Cancer Biomarker Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Biomarker Revenue, 2019-2030
6.5.2 China Prostate Cancer Biomarker Market Size, 2019-2030
6.5.3 Japan Prostate Cancer Biomarker Market Size, 2019-2030
6.5.4 South Korea Prostate Cancer Biomarker Market Size, 2019-2030
6.5.5 Southeast Asia Prostate Cancer Biomarker Market Size, 2019-2030
6.5.6 India Prostate Cancer Biomarker Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Biomarker Revenue, 2019-2030
6.6.2 Brazil Prostate Cancer Biomarker Market Size, 2019-2030
6.6.3 Argentina Prostate Cancer Biomarker Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, 2019-2030
6.7.2 Turkey Prostate Cancer Biomarker Market Size, 2019-2030
6.7.3 Israel Prostate Cancer Biomarker Market Size, 2019-2030
6.7.4 Saudi Arabia Prostate Cancer Biomarker Market Size, 2019-2030
6.7.5 UAE Prostate Cancer Biomarker Market Size, 2019-2030
7 Prostate Cancer Biomarker Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Major Product Offerings
7.1.4 Thermo Fisher Scientific Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 QIAGEN
7.2.1 QIAGEN Company Summary
7.2.2 QIAGEN Business Overview
7.2.3 QIAGEN Prostate Cancer Biomarker Major Product Offerings
7.2.4 QIAGEN Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.2.5 QIAGEN Key News & Latest Developments
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Summary
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Prostate Cancer Biomarker Major Product Offerings
7.3.4 Roche Diagnostics Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.3.5 Roche Diagnostics Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Biomarker Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Myriad Genetics
7.5.1 Myriad Genetics Company Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Prostate Cancer Biomarker Major Product Offerings
7.5.4 Myriad Genetics Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.5.5 Myriad Genetics Key News & Latest Developments
7.6 Sanofi-Aventis
7.6.1 Sanofi-Aventis Company Summary
7.6.2 Sanofi-Aventis Business Overview
7.6.3 Sanofi-Aventis Prostate Cancer Biomarker Major Product Offerings
7.6.4 Sanofi-Aventis Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.6.5 Sanofi-Aventis Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Prostate Cancer Biomarker Major Product Offerings
7.7.4 Pfizer Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 MDx Health
7.8.1 MDx Health Company Summary
7.8.2 MDx Health Business Overview
7.8.3 MDx Health Prostate Cancer Biomarker Major Product Offerings
7.8.4 MDx Health Prostate Cancer Biomarker Revenue in Global Market (2019-2024)
7.8.5 MDx Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Biomarker Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Biomarker Market Drivers in Global Market
Table 3. Prostate Cancer Biomarker Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Biomarker in Global Market
Table 5. Top Prostate Cancer Biomarker Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Prostate Cancer Biomarker Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Prostate Cancer Biomarker Revenue Share by Companies, 2019-2024
Table 8. Global Companies Prostate Cancer Biomarker Product Type
Table 9. List of Global Tier 1 Prostate Cancer Biomarker Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Biomarker Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Prostate Cancer Biomarker Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Prostate Cancer Biomarker Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Prostate Cancer Biomarker Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Prostate Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Prostate Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Prostate Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue, (US$, Mn), 2025-2030
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Prostate Cancer Biomarker Product Offerings
Table 32. Thermo Fisher Scientific Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. QIAGEN Company Summary
Table 35. QIAGEN Prostate Cancer Biomarker Product Offerings
Table 36. QIAGEN Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 37. QIAGEN Key News & Latest Developments
Table 38. Roche Diagnostics Company Summary
Table 39. Roche Diagnostics Prostate Cancer Biomarker Product Offerings
Table 40. Roche Diagnostics Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 41. Roche Diagnostics Key News & Latest Developments
Table 42. Beckman Coulter Company Summary
Table 43. Beckman Coulter Prostate Cancer Biomarker Product Offerings
Table 44. Beckman Coulter Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Myriad Genetics Company Summary
Table 47. Myriad Genetics Prostate Cancer Biomarker Product Offerings
Table 48. Myriad Genetics Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 49. Myriad Genetics Key News & Latest Developments
Table 50. Sanofi-Aventis Company Summary
Table 51. Sanofi-Aventis Prostate Cancer Biomarker Product Offerings
Table 52. Sanofi-Aventis Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 53. Sanofi-Aventis Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Prostate Cancer Biomarker Product Offerings
Table 56. Pfizer Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. MDx Health Company Summary
Table 59. MDx Health Prostate Cancer Biomarker Product Offerings
Table 60. MDx Health Prostate Cancer Biomarker Revenue (US$, Mn) & (2019-2024)
Table 61. MDx Health Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Biomarker Segment by Type in 2023
Figure 2. Prostate Cancer Biomarker Segment by Application in 2023
Figure 3. Global Prostate Cancer Biomarker Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Biomarker Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Biomarker Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2023
Figure 8. By Type - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 9. By Application - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 10. By Type - Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 12. By Application - Global Prostate Cancer Biomarker Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 14. By Region - Global Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 15. By Country - North America Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 16. US Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 20. Germany Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 21. France Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 28. China Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 32. India Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 34. Brazil Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Biomarker Revenue Market Share, 2019-2030
Figure 37. Turkey Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Prostate Cancer Biomarker Revenue, (US$, Mn), 2019-2030
Figure 41. Thermo Fisher Scientific Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. QIAGEN Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Roche Diagnostics Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Beckman Coulter Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Myriad Genetics Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Sanofi-Aventis Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. MDx Health Prostate Cancer Biomarker Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
